These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

258 related items for PubMed ID: 25689415

  • 21. Protective role of cannabinoid CB1 receptors and vascular effects of chronic administration of FAAH inhibitor URB597 in DOCA-salt hypertensive rats.
    Baranowska-Kuczko M, Kozłowska H, Kloza M, Karpińska O, Toczek M, Harasim E, Kasacka I, Malinowska B.
    Life Sci; 2016 Apr 15; 151():288-299. PubMed ID: 26969765
    [Abstract] [Full Text] [Related]

  • 22. Inhibition of fatty-acid amide hydrolase and CB1 receptor antagonism differentially affect behavioural responses in normal and PCP-treated rats.
    Seillier A, Advani T, Cassano T, Hensler JG, Giuffrida A.
    Int J Neuropsychopharmacol; 2010 Apr 15; 13(3):373-86. PubMed ID: 19607756
    [Abstract] [Full Text] [Related]

  • 23. Inhibition of 2-arachidonoylglycerol catabolism modulates vasoconstriction of rat middle cerebral artery by the thromboxane mimetic, U-46619.
    Hillard CJ, Ho WS, Thompson J, Gauthier KM, Wheelock CE, Huang H, Hammock BD.
    Br J Pharmacol; 2007 Nov 15; 152(5):691-8. PubMed ID: 17891162
    [Abstract] [Full Text] [Related]

  • 24. An endocannabinoid signaling system modulates anxiety-like behavior in male Syrian hamsters.
    Moise AM, Eisenstein SA, Astarita G, Piomelli D, Hohmann AG.
    Psychopharmacology (Berl); 2008 Oct 15; 200(3):333-46. PubMed ID: 18545985
    [Abstract] [Full Text] [Related]

  • 25. Increased Contextual Fear Conditioning in iNOS Knockout Mice: Additional Evidence for the Involvement of Nitric Oxide in Stress-Related Disorders and Contribution of the Endocannabinoid System.
    Lisboa SF, Gomes FV, Silva AL, Uliana DL, Camargo LH, Guimarães FS, Cunha FQ, Joca SR, Resstel LB.
    Int J Neuropsychopharmacol; 2015 Jan 24; 18(8):. PubMed ID: 25618404
    [Abstract] [Full Text] [Related]

  • 26. Enhancing Endocannabinoid Neurotransmission Augments The Efficacy of Extinction Training and Ameliorates Traumatic Stress-Induced Behavioral Alterations in Rats.
    Morena M, Berardi A, Colucci P, Palmery M, Trezza V, Hill MN, Campolongo P.
    Neuropsychopharmacology; 2018 May 24; 43(6):1284-1296. PubMed ID: 29265107
    [Abstract] [Full Text] [Related]

  • 27. Memory encoding in hippocampal ensembles is negatively influenced by cannabinoid CB1 receptors.
    Hampson RE, Sweatt AJ, Goonawardena AV, Song D, Chan RH, Marmarelis VZ, Berger TW, Deadwyler SA.
    Behav Pharmacol; 2011 Aug 24; 22(4):335-46. PubMed ID: 21558844
    [Abstract] [Full Text] [Related]

  • 28. Evaluation of the role of nicotinic acetylcholine receptor subtypes and cannabinoid system in the discriminative stimulus effects of nicotine in rats.
    Zaniewska M, McCreary AC, Przegaliński E, Filip M.
    Eur J Pharmacol; 2006 Jul 01; 540(1-3):96-106. PubMed ID: 16730696
    [Abstract] [Full Text] [Related]

  • 29. Effects of the FAAH inhibitor, URB597, and anandamide on lithium-induced taste reactivity responses: a measure of nausea in the rat.
    Cross-Mellor SK, Ossenkopp KP, Piomelli D, Parker LA.
    Psychopharmacology (Berl); 2007 Feb 01; 190(2):135-43. PubMed ID: 17111174
    [Abstract] [Full Text] [Related]

  • 30. Effects of cannabinoid and vanilloid receptor agonists and their interaction on learning and memory in rats.
    Shiri M, Komaki A, Oryan S, Taheri M, Komaki H, Etaee F.
    Can J Physiol Pharmacol; 2017 Apr 01; 95(4):382-387. PubMed ID: 28112976
    [Abstract] [Full Text] [Related]

  • 31. Interaction between cannabinoid compounds and diazepam on anxiety-like behaviour of mice.
    Naderi N, Haghparast A, Saber-Tehrani A, Rezaii N, Alizadeh AM, Khani A, Motamedi F.
    Pharmacol Biochem Behav; 2008 Mar 01; 89(1):64-75. PubMed ID: 18096213
    [Abstract] [Full Text] [Related]

  • 32. The cannabinoid transporter inhibitor OMDM-2 reduces social interaction: Further evidence for transporter-mediated endocannabinoid release.
    Seillier A, Giuffrida A.
    Neuropharmacology; 2018 Mar 01; 130():1-9. PubMed ID: 29169961
    [Abstract] [Full Text] [Related]

  • 33. Acute hypertension reveals depressor and vasodilator effects of cannabinoids in conscious rats.
    Ho WS, Gardiner SM.
    Br J Pharmacol; 2009 Jan 01; 156(1):94-104. PubMed ID: 19133994
    [Abstract] [Full Text] [Related]

  • 34. Revealing the role of the endocannabinoid system modulators, SR141716A, URB597 and VDM-11, in sleep homeostasis.
    Murillo-Rodríguez E, Machado S, Rocha NB, Budde H, Yuan TF, Arias-Carrión O.
    Neuroscience; 2016 Dec 17; 339():433-449. PubMed ID: 27746343
    [Abstract] [Full Text] [Related]

  • 35. URB597 and the Cannabinoid WIN55,212-2 Reduce Behavioral and Neurochemical Deficits Induced by MPTP in Mice: Possible Role of Redox Modulation and NMDA Receptors.
    Escamilla-Ramírez A, García E, Palencia-Hernández G, Colín-González AL, Galván-Arzate S, Túnez I, Sotelo J, Santamaría A.
    Neurotox Res; 2017 May 17; 31(4):532-544. PubMed ID: 28092019
    [Abstract] [Full Text] [Related]

  • 36. SLV330, a cannabinoid CB1 receptor antagonist, ameliorates deficits in the T-maze, object recognition and Social Recognition Tasks in rodents.
    de Bruin NM, Prickaerts J, Lange JH, Akkerman S, Andriambeloson E, de Haan M, Wijnen J, van Drimmelen M, Hissink E, Heijink L, Kruse CG.
    Neurobiol Learn Mem; 2010 May 17; 93(4):522-31. PubMed ID: 20132903
    [Abstract] [Full Text] [Related]

  • 37. Positive Allosteric Modulation of Cannabinoid Receptor Type 1 Suppresses Pathological Pain Without Producing Tolerance or Dependence.
    Slivicki RA, Xu Z, Kulkarni PM, Pertwee RG, Mackie K, Thakur GA, Hohmann AG.
    Biol Psychiatry; 2018 Nov 15; 84(10):722-733. PubMed ID: 28823711
    [Abstract] [Full Text] [Related]

  • 38. Cannabinoid receptor agonist WIN55,212-2 and fatty acid amide hydrolase inhibitor URB597 suppress chronic cerebral hypoperfusion-induced neuronal apoptosis by inhibiting c-Jun N-terminal kinase signaling.
    Su SH, Wu YF, Lin Q, Yu F, Hai J.
    Neuroscience; 2015 Aug 20; 301():563-75. PubMed ID: 25795598
    [Abstract] [Full Text] [Related]

  • 39. Brain-Permeant and -Impermeant Inhibitors of Fatty Acid Amide Hydrolase Synergize with the Opioid Analgesic Morphine to Suppress Chemotherapy-Induced Neuropathic Nociception Without Enhancing Effects of Morphine on Gastrointestinal Transit.
    Slivicki RA, Saberi SA, Iyer V, Vemuri VK, Makriyannis A, Hohmann AG.
    J Pharmacol Exp Ther; 2018 Dec 20; 367(3):551-563. PubMed ID: 30275151
    [Abstract] [Full Text] [Related]

  • 40. Inhibition of fatty acid amide hydrolase reduces reinstatement of nicotine seeking but not break point for nicotine self-administration--comparison with CB(1) receptor blockade.
    Forget B, Coen KM, Le Foll B.
    Psychopharmacology (Berl); 2009 Sep 20; 205(4):613-24. PubMed ID: 19484221
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.